ArticlePDF Available

Effects of music therapy as an adjunct to chest physiotherapy in children with cystic fibrosis: A randomized controlled trial

Authors:

Abstract and Figures

Airway clearance therapy (ACT) is considered an important approach to improve airway clearance in children with cystic fibrosis (CF). Daily ACT administration requires substantial commitments of time and energy that complicate ACT and reduce its benefits. It is crucial to establish ACT as a positive routine. Music therapy (MT) is an aspect of integrative strategies to ameliorate the psycho-emotional consequences of chronic diseases, and a MT intervention could help children with CF between the ages of 2 and 17 develop a positive response. The aim of this randomized controlled trial was to evaluate the effects of specifically composed and recorded instrumental music as an adjunct to ACT. We compared the use of specifically composed music (Treated Group, TG), music that the patient liked (Placebo Group, PG), and no music (Control Group, CG) during the usual ACT routine in children with CF aged from 2 to 17. The primary outcomes, i.e., enjoyment and perception of time, were evaluated via validated questionnaires. The secondary outcome, i.e., efficiency, was evaluated in terms of avoided healthcare resources. Enjoyment increased after the use of the specifically composed music (children +0.9 units/parents +1.7 units; p<0.05) compared to enjoyment with no music (0 units) and familiar music (+0.5 units). Perception of time was 11.1 min (±3.9) less than the actual time in the TG (p<0.05), 3.9 min (±4.2) more than the actual time in the PG and unchanged in the CG. The potential cost saving related to respiratory exacerbations was €6,704.87, while the cost increased to €33,524.35 in the CG and to €13,409.74 in the PG. In conclusion, the specifically composed, played and compiled instrumental recorded music is an effective adjunct to ACT to establish a positive response and is an efficient option in terms of avoided costs. Trial registered as ISRCTN11161411. ISRCTN registry (www.isrctn.com).
Content may be subject to copyright.
RESEARCH ARTICLE
Effects of music therapy as an adjunct to chest
physiotherapy in children with cystic fibrosis:
A randomized controlled trial
Alberto Montero-Ruiz
1,2
, Laura A. Fuentes
1
, Estela Pe
´rez Ruiz
1,3
, Nuria Garcı
´a-Agua
Soler
1
, Francisca Rius-Diaz
4
, Pilar Caro Aguilera
1,3
, Javier Pe
´rez Frı
´as
1,3
*, Elisa Martı
´n-
MontañezID
1
*
1Departamento de Farmacologı
´a y Pediatrı
´a, Universidad de Ma
´laga, Instituto de Investigacio
´n Biome
´dica
de Ma
´laga, Facultad de Medicina, Ma
´laga, Spain, 2Consejerı
´a de Educacio
´n, Junta de Andalucı
´a,
Delegacio
´n Territorial de Ma
´laga, Ma
´laga, Spain, 3Hospital Regional Universitario de Ma
´laga, Seccio
´n de
Neumologı
´a Pedia
´trica, Ma
´laga, Spain, 4Departamento de Medicina Preventiva y Salud Pu
´blica,
Universidad de Ma
´laga, Facultad de Medicina, Ma
´laga, Spain
*emartinm@uma.es (EM-M); jpf@uma.es (JPF)
Abstract
Airway clearance therapy (ACT) is considered an important approach to improve airway
clearance in children with cystic fibrosis (CF). Daily ACT administration requires substantial
commitments of time and energy that complicate ACT and reduce its benefits. It is crucial to
establish ACT as a positive routine. Music therapy (MT) is an aspect of integrative strategies
to ameliorate the psycho-emotional consequences of chronic diseases, and a MT interven-
tion could help children with CF between the ages of 2 and 17 develop a positive response.
The aim of this randomized controlled trial was to evaluate the effects of specifically com-
posed and recorded instrumental music as an adjunct to ACT. We compared the use of spe-
cifically composed music (Treated Group, TG), music that the patient liked (Placebo Group,
PG), and no music (Control Group, CG) during the usual ACT routine in children with CF
aged from 2 to 17. The primary outcomes, i.e., enjoyment and perception of time, were eval-
uated via validated questionnaires. The secondary outcome, i.e., efficiency, was evaluated
in terms of avoided healthcare resources. Enjoyment increased after the use of the specifi-
cally composed music (children +0.9 units/parents +1.7 units; p<0.05) compared to enjoy-
ment with no music (0 units) and familiar music (+0.5 units). Perception of time was 11.1 min
(±3.9) less than the actual time in the TG (p<0.05), 3.9 min (±4.2) more than the actual time
in the PG and unchanged in the CG. The potential cost saving related to respiratory exacer-
bations was 6,704.87, while the cost increased to 33,524.35 in the CG and to 13,409.74
in the PG. In conclusion, the specifically composed, played and compiled instrumental
recorded music is an effective adjunct to ACT to establish a positive response and is an effi-
cient option in terms of avoided costs.
Trial registered as ISRCTN11161411. ISRCTN registry (www.isrctn.com).
PLOS ONE
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 1 / 15
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Montero-Ruiz A, Fuentes LA, Pe
´rez Ruiz
E, Garcı
´a-Agua Soler N, Rius-Diaz F, Caro Aguilera
P, et al. (2020) Effects of music therapy as an
adjunct to chest physiotherapy in children with
cystic fibrosis: A randomized controlled trial. PLoS
ONE 15(10): e0241334. https://doi.org/10.1371/
journal.pone.0241334
Editor: Nancy Beam, PLOS ONE, UNITED STATES
Received: June 15, 2019
Accepted: October 12, 2020
Published: October 30, 2020
Copyright: ©2020 Montero-Ruiz et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: This research was supported by the
project PIN-0342-2016 from Consejerı
´a de Salud
de la Junta de Andalucı
´a and Plan Propio de
Investigacio
´n de la Universidad de Ma
´laga. The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Introduction
Cystic fibrosis (CF) is an inherited autosomal recessive multisystemic disease characterized
mainly by respiratory and digestive disorders [1,2]. Due to a defect in the CF transmembrane
conductance regulator gene, excess dehydrated and thick secretions are produced in the lungs,
liver, pancreas, intestine, sweat and salivary glands and reproductive organs [3]. The cause of
morbi-mortality is linked to respiratory manifestations due to the accumulation of mucus in the
airways, which ultimately leads to secondary infections, bronchiectasis, and respiratory failure
[2]. Routine airway clearance therapy (ACT) is one of the main approaches used to improve air-
way clearance [4,5]. These airway clearance techniques are prescribed daily and, in the case of
children, are to be given by their parents until children and adolescents are old enough to be
actively involved in their own ACT. Therefore, ACT is well established as an integral part of the
management of CF and is aimed at minimizing symptoms, reducing the frequency of exacerba-
tions and improving lung function [5]. However, ACT requires substantial commitments of
time and energy, leading to low levels of ACT adherence [6] and decreases in its benefits [7].
Individuals with CF and their parents report elevated symptoms of psychological burden
[8]. To avoid these negative effects related to this daily routine, it is important to establish ACT
as an enjoyable task, and a music therapy (MT) strategy could help people with CF develop a
positive response. In pulmonary diseases, MT interventions are components of integrative
strategies adopted to ameliorate physical or psycho-emotional consequences [9,10]; however,
MT interventions in CF are infrequent, and in any case very few. To our knowledge, only five
studies have evaluated the effects of music-based strategies, based on playing instruments [11],
singing [12,13] or listening to music [14,15], as adjunct therapy in children with CF. In this
sense, it has been shown that listening to carefully selected motivational music while walking,
which was chosen by physiotherapists, can lead to a positive affective response during exercise,
increasing the enjoyment of exercise in CF patients between the ages of 8 and 18 [15]. Further-
more, a study carried out in children with CF who were less than 24 months old indicated that
listening to specifically composed and recorded music as an adjunct to ACT increased chil-
dren’s and parents’ enjoyment of ACT and assisted in the establishment of a positive routine
[14]. Although Calik-Kutukcu and colleagues [15] showed that listening to selected motiva-
tional music can have a positive effect on exercise, Grasso and colleagues [14] revealed that lis-
tening to recorded music specifically composed, is an effective mean to increase the positive
effects found during ACT routine with toddler, being more effective than familiar music. We
planned this clinical trial considering the importance of these specific characteristics to
enhance the positive effect of music [14] and also, the lack of literature on the use of music
during ACT with CF children older than 24 months old. Thus, the purpose of the current
study was to evaluate the effects of listening to specifically composed, played and recorded
music as an adjunct to ACT in children with CF older than 2 years old. We hypothesized that
the use of the specifically composed music may provide benefits compare to patients-preferred
music or the use of no music. The primary aims were to examine (1) a possible increase in
patients’ and parents’ enjoyment of the ACT routine and (2) a possible decrease in perception
of time taken to complete the routine. As a secondary aim, we wanted to analyze the efficiency
of the music therapy intervention in terms of avoided healthcare resources.
Materials and methods
Study participants
Individuals with CF between the ages of 2 and 17 were recruited from the Pediatric Pulmonol-
ogy Unit at Malaga Regional Hospital, which was providing care to 80 people with CF at the
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 2 / 15
Competing interests: The authors have declared
that no competing interests exist.
time of study. Participants who met all of the inclusion criteria, none of the exclusion criteria
(Table 1) and provided written informed consent were included in the trial. Due to all the par-
ticipants were minors, written informed consent was obtained from their parents, which was
also signed by children aged >12.
The study was conducted according to the Declaration of Helsinki and was approved by the
Ethics in Human Research Committee of Malaga Regional Hospital on October 27, 2016. The
authors confirm that all ongoing and related trials for this intervention are registered. We reg-
istered the trial on the ISRCTN registry (ISRCTN11161411: www.isrctn.com.) on June 15,
2019. Patient recruitment and follow-up were conducted from February 1, 2018 to July 31,
2018. The delay in registering this study in a publicly accessible register was because the trial
was previously registered in the Andalusian Ethics Biomedical Research Registry (PEIBA) in
October 2016. Thus, the trial was registered before recruiting the first participant in the study.
We thought the PEIBA register was included in the WHO list of approved registries, but in
June 2019, we realized that the PEIBA registry was not a publicly accessible registry; therefore,
we decided to register the trial in the ISRCTN registry immediately.
Study design
The MT intervention evaluated consisted of the use of instrumental music that was specifically
composed, played and compiled for children with CF and that was used as an adjunct to each
part of the ACT routine without modifying the usual treatment regimens or programmed clinic
visits; therefore, there was no risk of harm. We compared the use of this specifically composed
music with (1) the use of music the patients liked, also called familiar music, and (2) the use of
no music during ACT management. The participants were randomly allocated using the ‘Sub-
jects assignment to treatment’ module of the software for the epidemiologic analysis of tabulated
data Epidat (version 3.1) [18]. A design for equal-sized groups was chosen. After we set the num-
ber of groups (n = 3) and the total sample size (n = 54), Epidat made a random assignment
according to the participant order number, with each participant assigned to one of the 3 follow-
ing conditions: (1) Treated Group (TG)–use of the specifically composed music as an adjunct to
the ACT routine; (2) Placebo Group (PG)–use of music the patients liked as an adjunct to the
ACT routine; and (3) Control Group (CG)–the standard practice of the ACT routine.
Table 1. Clinical trial inclusion and exclusion criteria.
Inclusion
criteria
Participants diagnosed with CF based on international criteria [16]: a positive sweat test (chloride
value 60 mmol/L); 2 CF-causing CFTR mutations; and clinical features compatible with CF
Participants undergoing periodic clinic visits in the CF unit
Participants in the target age range
Participants with an understanding of the purpose of the study
Exclusion
criteria
Participants without ACT prescription
Participants with severe hearing loss
Participants with clinical complications such that the ACT may have to be adapted or may be
contraindicated: radiologic or clinical risk of pneumothorax or pneumomediastinum;
barotrauma in the month prior to entry in the study; or past history of massive or life-threatening
hemoptysis [17]
Transplant recipients or patients awaiting a lung transplant
Abbreviations: CF, cystic fibrosis; CFTR, cystic fibrosis transmembrane conductance regulator; ACT, airway
clearance therapy.
Information about the clinical variables (age of diagnosis, body mass index, Bhalla score and respiratory infection
exacerbations) was obtained from the clinical center.
https://doi.org/10.1371/journal.pone.0241334.t001
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 3 / 15
In our Pediatric Pulmonology Unit, ACT is divided into 3 sections: nebulizer inhalation
treatment, airway clearance techniques and relaxation/antibiotic nebulizer treatment, if neces-
sary. Participants in the TG were given a music CD with music that was composed, played and
compiled specifically for children with CF by a professional musician and music teacher under
the recommendations of the CF specialists at the Pediatric Pulmonology Unit. The recommen-
dations provided for developing the music were (1) to encourage enjoyment; (2) to elicit relax-
ation, maintaining children’s interest to facilitate deep inhalation during the inhaled treatment
sections; (3) to provide appropriate rhythmic support for the management of airway clearance
techniques to improve mucus clearance; and (4) to promote distraction from the time spent
on the routine. The CD consisted of instrumental composed music played on percussion
instruments to use as an adjunct to ACT during the 3-month trial period. The music CD had 3
sections related to the ACT routine: section A for the nebulizer treatment, section B for ACT
work and bronchial clearance and section C for relaxation and nebulization. The CD was 40
min long, corresponding to the average length of the ACT routine. Section A contained 4 slow
songs (65 bpm) with a total of 13 min of relaxing music for the duration of the nebulizer
inhalation treatment. Section B consisted of 5 moderate rhythmical songs (mean = 112.4 bpm)
and was a total of 23 min long; it provided a rhythmic structure to support the management of
airway clearance techniques such as huffing, coughing, percussions or vibrations. Section C
was a 4-min-long relaxing song that was a variation of a section A song. The music was per-
formed with pitched percussion instruments (marimba, vibes, glockenspiel and xylophone)
and unpitched percussion instruments (drums, congas, bongos, multipercussion set and small
percussion instruments) that are widely used in MT interventions [19,20]. MuseScore software
was used to write the scores, and the software Audacity was used to record and edit the audio.
The music was compiled on a CD. Participants in the PG were given recommendations for the
use of familiar music as an adjunct to ACT during the 3-month trial period. The recommenda-
tions encouraged the patients to listen to slow, relaxing music that they liked during the first
and last ACT sections, and moderate rhythmical songs in the middle section. The CG was
composed of participants who were asked to continue with their usual ACT routine during the
3-month trial period. Participants in these 2 groups (PG and CG) were given the music CD to
keep at the end of the study.
Questionnaires designed and validated by Grasso and colleagues were employed in the cur-
rent study [14]. We evaluated the internal consistency by calculating Cronbach’s alpha coeffi-
cient among the items referring to the ‘enjoyment’ construct in an independent sample of
people with CF over 18 and their parents [14] (Cronbach’s alpha = 0.856).
Participants completed a baseline questionnaire, a follow-up questionnaire and an evalua-
tion questionnaire during the 3-month trial period. The baseline questionnaire was completed
in a face-to-face interview immediately following recruitment during a routine clinic visit. The
follow-up and the evaluation questionnaires were completed via telephone interviews 6 and 12
weeks after the first interview, respectively. We used the middle questionnaire collecting infor-
mation about experience with physiotherapy routine as a follow-up strategy, instead of evaluat-
ing the intervention. Nonclinical research staff performed the interviews and was trained
previously. Adolescent participants completed questionnaires independently and were given
the option to have their parents join them for the interviews. In all cases, the parents of adoles-
cents joined. After the baseline questionnaire, participants received a reference sheet contain-
ing the Likert-type response scales and a list of descriptive words for reference during the
telephone interviews. This reference sheet was also posted on the MT intervention website (an
additional support for participants, which included a summary of the intervention, the refer-
ence sheet and contact information).
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 4 / 15
Outcome measures
The primary outcomes, i.e., enjoyment and perception of time, were evaluated via the validated
questionnaires specified above [14]. Enjoyment was assessed on 7-point Likert-type scales
completed by participants, where +3 was the most enjoyment, 0 was neutral and 3 was the
least enjoyment. Participants also chose 3 descriptive words from a list of 12 words that best
described their own experiences of ACT. Parents ranked their own enjoyment and their chil-
dren’s enjoyment on these scales when the children were under 8 years old. Parents also chose
the 3 descriptive words in these cases.
Perception of time was assessed as the difference between the actual time taken to complete
ACT (measured using a stopwatch) and the apparent time to complete ACT (subjective per-
ception) [14]. The actual time was evaluated as the response (given in minutes) to the question
‘How long does the ACT routine take?’ The apparent time was evaluated as the response
(given in minutes) to the question ‘How long does it feel like it takes to complete ACT?’.
The secondary outcome, i.e., efficiency of the intervention, was evaluated in terms of
avoided healthcare resources to treat respiratory infection exacerbations that required hospi-
talization. The number of exacerbations and the number of days hospitalized during the previ-
ous 3 months and during the 3-month trial period were obtained from the clinic history.
Hospitalization cost (expressed in Euros) was estimated based on the associated diagnosis-
related group (DRG) (DRG 131: CF-Pulmonary disease, average hospitalization: 11.14 days)
[21]. The DGR is a unit for classifying patients by diagnosis, average length of hospital stay
and therapy received.
Statistical analysis
To calculate the sample size, the perception of time taken to complete ACT was used as the
main variable. In the study by Grasso [14], the control group values for this variable were 0.2
min ±10.2 (mean ±SD); based on an assumption of these values as a baseline, a power of 80%,
a confidence level of 95%, and a similar variability at the end of the study, a difference of 8 min
would be considered statistically significant with a sample size of 13 participants. A total of 39
participants are necessary to enable a valid answer to the research question. The variables are
expressed as the mean (±SD) or n (%). To compare quantitative measures, ANOVA/Kruskal-
Wallis tests were used, while chi-square test was used for the qualitative demographic variable
‘gender’. To compare the differences in the change in the variables between the different
groups, from a global point of view, a repeated measures multivariate analysis of variance
(MANOVA) test was applied with a between-participants factor (different groups) and a
within-participants factor (different time points of data collection). Depending on compliance
with the assumption of sphericity, Greenhouse-Geisser correction was used. Box test and
Levene test were used to ensure homogeneity of covariance matrices and error variances,
respectively. To more specifically compare the differences between the baseline and final mea-
sures in each group, the Wilcoxon test was applied. To compare the response to the use of
music after the intervention in the TG and PG, the Mann–Whitney U test was used. Statistical
significance was declared at the 0.05 level. Statistical analysis was performed using SPSS soft-
ware (version 24.0; IBM SPSS Statistics, Chicago, IL).
Results
A total of 54 patients met all the inclusion criteria and agreed to participate in the intervention.
As we explain in the study design, the participants were randomly allocated into the TG
(n = 18), PG (n = 18) and CG (n = 18). Eleven patients were withdrawn when they could not
be contacted by telephone to be interviewed (n = 3), rejected their consent (n = 2) or used the
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 5 / 15
music CD (n = 2) or familiar music (n = 4) as an adjunct the ACT less than 50% of the time,
leaving a total of 15 patients in the TG, 15 patients in the CG, and 13 patients in the PG (Fig 1).
The percentage of participants who withdrew from the study (20.4%) was lower than the
potential withdrawal estimated for the study (27.8%, 15 participants). The groups had similar
withdrawal distribution.
The demographic and clinical data and ACT variables are shown in Table 2; the data reflect
standard characteristics of the population of children with CF and show no statistically signifi-
cant differences between groups in the baseline measures.
Concerning the baseline use of adjuncts to ACT prior to the intervention, the most com-
mon adjuncts to ACT were the use of television or other audiovisual devices by 28 (66.7%) par-
ticipants, while music was used by 10 (23.8%) participants. There were no statistically
significant differences in the ACT baseline adjunct measures between the 3 groups. During the
intervention, audiovisual devices were frequently used as adjuncts to ACT in the CG (12,
80%), while 12 (80%) and 11 (73.3%) patients in the TG used the music CD frequently after 6
Fig 1. Flow diagram of the clinical trial.
https://doi.org/10.1371/journal.pone.0241334.g001
Table 2. Demographic and clinical data and baseline ACT variables.
Parameters Control Group (n = 15) Placebo Group (n = 13) Treated Group (n = 15)
Age, years
1
7.2 ±4.3 (2–16) 8.1 ±5.6 (2–17) 7.9 ±4.7 (2–17)
Age of diagnosis, months
1
6.8 ±8.4 (0.5–24) 6.8 ±6.8 (1–24) 6.4 ±7 (0.5–24)
Male
2
8 (53.3) 9 (69.2) 10 (66.7)
BMI
3
16.6 ±1.7 (13.7–19.4) 16.3 ±2.2 (12.1–19.1) 16.9 ±2.2 (12.8–19.6)
Bhalla score
1
19.4 ±3.8 (13–25) 18 ±5 (10–25) 18.9 ±4.7 (9–24)
ACT frequency per day
1
1.3 ±0.5 (1–2) 1.4 ±0.5 (1–2) 1.4 ±0.5 (1–2)
Time to take an ACT session, minutes
3
26 ±3.4 (10–60) 22.4 ±3.7 (10–45) 27.3 ±3.4 (10–60)
Continuous variables are expressed as the mean ±SD (range). Categorical data are expressed as n (%).
1
Median ±SD (range): Kruskal-Wallis test was performed to compare groups.
2
N (%): Chi square test was performed to compare groups for the variable ’gender’.
3
Median ±SD (range): ANOVA test was performed to compare groups. No statistically significant differences were identified.
Abbreviations: BMI, body mass index; ACT, airway clearance therapy. Bhalla score: a lung damage severity rating system for high-resolution computed tomography in
cystic fibrosis. The lower the Bhalla score is, the more severe the condition [22].
https://doi.org/10.1371/journal.pone.0241334.t002
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 6 / 15
or 12 weeks, respectively. The frequent use of familiar music decreased during the interven-
tion, being used by 10 (76.9%) participants after 6 weeks and 6 (46.2%) participants after 12
weeks. Throughout, participants in the TG and PG used music more than 50% of the time.
The results on children’s enjoyment are shown in Fig 2A. The differences between the 3
groups did not reach statistical significance (group, p = 0.197). However, the change over time
in children’s enjoyment between the groups was statistically significant (interaction,
p = 0.042), and a statistically significant change in children’s enjoyment before and after the
intervention (time points, p = 0.006) was observed. The use of the specifically composed music
or the familiar music was associated with a positive change in children’s perceived enjoyment
of ACT after 12 weeks compared to the use of no music. Thus, the change in enjoyment from
baseline was +0.9 units for the TG (p = 0.004) and +0.56 units (p = 0.035) for the PG compared
with no change in the CG (-0.06 units). A similar response was observed for parents’ enjoy-
ment (Fig 2B); the use of the music CD (+1.7 units, p = 0.009) and familiar music (+0.5 units)
was associated with a positive change in parents’ perceived enjoyment of ACT after 12 weeks
compared with no music (+0.14 units). Again, the differences between the 3 groups did not
reach statistical significance (group, p = 0.493). However, the change over time in parents’
enjoyment between the groups was statistically significant (interaction, p = 0.011), and a statis-
tically significant change in parents’ enjoyment before and after the intervention (time points,
p = 0.001) was observed.
Moreover, the evaluation of the descriptive words chosen to describe the response to ACT
showed that, after use of the music CD, no negative responses were expressed by the children
and parents, while prior to the use of the specific music, 6 (40%) children and 4 (30.8%)
parents expressed negative perceptions. No changes in negative response were observed in the
CG or PG patients or parents. In addition, no adverse effects from the experimental conditions
were observed.
Concerning the analysis of the outcome ’perception of time’, based on Grasso and col-
leagues study [14], the perception of time taken to complete the ACT routine changed posi-
tively after the intervention. Thus, the use of music CD as an adjunct to ACT routine not only
eliminated the feeling of spending much more time taking the ACT routine, but also led par-
ticipants to feel the length of the ACT 11.1 min (±3.9) shorter than the actual time they spent
to carry it out. However, PG and CG continued feeling the length of ACT routine longer than
the actual time they spent taking it. Thus, PG felt the length of routine 3.9 min (±4.2) longer
than actual time, and no changes were observed in the CG, feeling the length of the routine 9.0
min (±3.9) longer than actual time (Fig 3). A statistically significant change in the perception
of time before and after the intervention (time points, p = 0.001), a statistically significant
interaction of time and group (interaction, p = 0.004), and statistically significant differences
in the perception of time between the 3 groups (group, p = 0.038) were observed (Fig 3).
The analysis of the use of the specifically composed, played and compiled music as an
adjunct to ACT compared to the use of familiar music chosen based on the recommendations
given in the study showed a clear positive response in children and parents (2.0±1.4 units, in
both cases) to the use of the music CD and a positive response to the use of familiar music (1.0
±1.4 units, children; 0.9±1.4 units, parents), with statistically significant differences (p = 0.029,
children; p = 0.026, parents). In addition, the music CD was considered useful by 14 (93.3%)
participants (p = 0.023), while the familiar music was useful only to 7 (53.8%). All participants
except one (93.3%) in the TG reported that they would consider using this music or new
recorded music in the future (p = 0.03), but only 5 (38.5%) participants in the PG said they
would consider the use of familiar music. Anecdotal reports indicated that the music CD facili-
tated the relaxation of children and increased enjoyment of ACT (12, 85.7%), helping divert
children’s and parents’ attention away from the time spent on ACT. An enhancement of ACT
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 7 / 15
Fig 2. Change in children’s and parents’ enjoyment. (A) Children’s and (B) parents’ enjoyment. Enjoyment was assessed on 7-point Likert-type
scales, where—3 was the least enjoyment, + 3 was the most enjoyment, and 0 was neutral. Values were measured at baseline and in the final
interviews. The data are presented as the mean (±SD). Wilcoxon test was performed to compare the differences between the baseline and final
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 8 / 15
management was also reported. However, only 2 (28.6%) participants in the PG reported these
facts. Concerning the time to take an ACT session, the TG tended to spend more time per ses-
sion than the PG (37.1±18.9 min vs. 27.2±12.1 min, p = 0.09).
The number of respiratory infection exacerbations that required hospitalization in each
group and their related cost are shown in Table 3. The average length of hospital stay was
13.66 days. According to the official DRG prices published in Spain, a hospitalization for CF
costs a total of 6,704.87. As we can observe, only one child suffered an exacerbation during
the intervention in the TG, while 3 and 6 exacerbations were reported in the PG and CG,
respectively. Conversely, during the preintervention period, 2 exacerbation episodes were suf-
fered in the TG group, and one each was reported in the PG and CG groups. Based on these
data, the use of the music CD as an adjunct in the ACT yielded a potential cost saving of
6,704.87. However, in the CG, the cost increased to 33,524.35, and in the PG, the cost
increased to 13,409.74.
Discussion
The results of this study indicate that the specifically composed, played and compiled instru-
mental recorded music is an effective adjunct to ACT. Overall, its use demonstrates effective-
ness in improving children’s and parents’ enjoyment of ACT, reducing the perception of time
taken to complete ACT. Furthermore, the use of the music CD can be considered an efficient
option in terms of the avoided costs related to respiratory infection exacerbations.
Although patients and parents consider ACT to be an integral part of CF management, they
report serious difficulties in carrying it out [23,24]. Chest physiotherapy requires significant
measures in each group. Changes in children’s enjoyment: p = 0.004 (Treated Group);
&
p = 0.035 (Placebo Group); p = 0.89 (Control Group).
Changes in parents’ enjoyment: p = 0.009 (Treated Group); p = 0.096 (Placebo Group); p = 0.492 (Control Group).
https://doi.org/10.1371/journal.pone.0241334.g002
Fig 3. Change in perception of time. To analyze the perception of time, the apparent time value reported on the questionnaire was subtracted from the
actual time value given (actual time—apparent time = perception of time). Positive value: perception of ACT shorter. Negative value: perception of ACT
longer. Values above 0: participants felt they spent less time taking the ACT routine than the actual time they spent to taking it. Values below 0:
participants felt they spent more time taking the ACT routine than the actual time they spent taking it. Differences were calculated at baseline and the final
interviews. The data are presented as the mean (±SD). Wilcoxon test was performed to compare the differences between the baseline and final measures in
each group. Changes: p = 0.003 (Treated Group); p = 0.076 (Placebo Group); p = 0.857 (Control Group).
https://doi.org/10.1371/journal.pone.0241334.g003
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 9 / 15
commitments of time and energy, being crucial to establish ACT as a well-structured positive
routine [7,2325]. Providing enjoyable and stimulating strategies can be an effective tool for
increasing the participation of the population in health-oriented activities [26]. In rehabilita-
tion programs for chronic obstructive pulmonary disease, patient enjoyment is a factor
enabling patients to engage in these programs [27,28]. These enjoyable innovative strategies
also include MT interventions that are carried out in the home or community groups [2931].
Regarding children with CF, the use of the music CD as an adjunct to ACT elicited a positive
affective response in patients and parents, in line with the findings reported in infants for the
use of specific music during ACT [14] or the use of motivational music while walking by chil-
dren with CF [15]. Concerning the utilization of familiar music based on recommendations,
enjoyment was also increased, and similar results were also found in infants [14]. However,
the characteristics of the music compiled on the CD duplicated the positive effect of familiar
music, with the music CD being the best option. In addition, no negative descriptive words
about ACT were chosen by children or parents after using the music CD. It is evident that cer-
tain musical elements that were taken into account at the time of the composition and playing
of this therapeutic music had an important influence on the positive attitudes that were
observed. Therefore, the results of the current work together with the previous infant study
[14] indicate that music could be used to assist in the establishment of ACT as a positive rou-
tine and that the use of particular music that is composed, played and compiled specifically for
children with CF enhances this positive effect.
The music CD used in the current study incorporated elements to encourage positive
responses, ACT rhythmical interaction and distraction. Thus, the music included fluid
rhythms [32], varied and bright timbres [3234], intensity changes that were not excessively
marked [32,33], variable sound frequencies [32] and mainly major tonalities [35]. Moreover,
the music CD incorporated slow rhythms [15,36], intervals and consonant chords [34,37] and
sounds without excessively rapid vibrations [33] to elicit relaxation.
Music therapy studies in the pediatric context have demonstrated that the selection of
appropriate music and its elements can positively alter children’s experiences of medical inter-
ventions through distraction and/or relaxation [3845]. Therefore, it is known that induced
relaxation during appropriate music listening is one of the novel MT strategies implemented
in the management of pulmonary diseases [46]. Relaxation is essential in the course of drug
inhalation to achieve an optimal drug concentration in the lungs. In this study, the music CD
could facilitate distraction and relaxation during ACT, improving the management of the own
ACT. Thus, reports about the use of the music CD suggest that the music itself provided dis-
traction, relaxation and rhythmic support for the management of nebulizer inhalation treat-
ment and airway clearance techniques. In addition, because the music CD was structured in 3
sections with similar lengths to each ACT section, children and/or parents were not required
to time the sections of ACT, and the music reportedly distracted them from the time spent on
the routine.
Table 3. Healthcare resources in children with cystic fibrosis according to the different groups.
Groups Preintervention During the intervention Change
Exacerbations (n) Related cost () Exacerbations (n) Related cost () Exacerbations (n) Related cost ()
Treated (n = 15) 2 13,409.74 1 6,704.87 -1 -6,704.87
Placebo (n = 13) 1 6,704.87 3 20,114.61 +2 +13,409.74
Control (n = 15) 1 6,704.87 6 40,229.22 +5 +33,524.35
Preintervention: 3-month period before the intervention; intervention: 3-month trial period; exacerbation: number of respiratory infection exacerbations that required
hospitalization. Hospitalization cost () was estimated based on the associated diagnosis-related groups.
https://doi.org/10.1371/journal.pone.0241334.t003
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 10 / 15
Regarding the clear change in perception of time observed after using the music CD, it is
evident that certain music elements have an important influence on this variable. Certainly,
the use of the music CD decreased the perception of ACT as a long activity, while this effect
was not found in the PG or CG. Although no significant change in perception of time was
observed in the infant study [14], the anecdotal responses indicated that the time spent doing
ACT with specific recorded music seemed to pass more quickly than during their usual
routine.
Music can be effective as a distracting stimulus when used in pulmonary rehabilitation
training for chronic obstructive pulmonary disease. Among the benefits of music is an increase
in the total time spent on therapy sessions [47,48]. In this sense, the music CD also had an
effect on the time to take an ACT session in our study. During the intervention, the use of the
CD increased the time spent per session, making the time spent close to the required session
time [5,49]. Furthermore, 2 patients in the TG increased the ACT frequency per day from one
to 2 times.
Regarding the evaluation of its efficiency, although our MT strategy was longer than many
MT interventions that have been carried out for pulmonary diseases (2 to 10 week time span)
[10,12,13,30,50], the measure of rate of lung function decline (as FEV1% predicted/year), may
not be appropriate [51,52]. Therefore, we had to use a clinical outcome that could be measured
during this follow-up, i.e., respiratory infection exacerbations. Thus, the efficiency of the inter-
vention was evaluated in terms of avoided healthcare resources to treat respiratory infection
exacerbations that required hospitalization, and the use of the music CD as an adjunct to ACT
could represent a potential cost saving.
Other factors that could affect the results were not analyzed, for instance, those focused on
enhancing the management of ACT [53,54]. The most appropriate ACT and its management
for each child are assessed in our Pediatric Pulmonology Unit periodically. However, some
home environment factors, such as physical space, are hardly controllable.
The strength of the current intervention is that the study design included an independent
PG. However, participants in the CG in the infant study [14] experienced 2 conditions: a con-
trol and a placebo.
This study has limitations. First, our results were based on data from a single center. How-
ever, this study included half of the children with CF in our region with more than 8 million
inhabitants. Second, due to the nature of intervention, it was only possible to blind outcome
assessors, and there may be potential bias. Third, 11 participants were withdrawn from the
study because they could not be contacted by telephone to be interviewed (n = 3), rejected
their consent as a result of family moved (n = 2) or used the music CD (n = 2) or familiar
music (n = 4) as an adjunct the ACT less than 50% of the time, but the number withdrawn was
still lower than that initially estimated for this study (15 participants). Moreover, the with-
drawn participants were similarly distributed among the 3 groups, with the final sample size
equal to or above the sample size necessary in each group to enable valid answers to the
research question (13 participants).
Further long-term studies are needed to analyze whether this positive experience of ACT
has any sustained effects, patients’ perspectives, as well as the efficiency of the intervention in
terms of lung function.
In summary, we present the first MT intervention for children with CF between the ages of
2 and 17, demonstrating that the specifically composed, played and compiled instrumental
recorded music is an effective adjunct to ACT without adverse reactions and is an efficient
option in terms of avoided costs. The music CD improves children’s and parents’ enjoyment
of ACT, reducing the perception of time taken to complete ACT. Moreover, this music can
provide ACT rhythmic support, distraction and relaxation improving the management of the
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 11 / 15
own ACT. Therefore, this MT intervention we can expect better clinical outcomes in CF
patients without changes in treatment regimens or programmed clinic visits in CF units.
Supporting information
S1 File. CONSORT checklist.
(PDF)
S2 File. Trial study protocol—original.
(PDF)
S3 File. Trial study protocol—english version.
(PDF)
S4 File. Music characteristics.
(DOCX)
S5 File. Music scores.
(PDF)
S6 File. Questionnaires. Music CD. Because the recorded music was compiled in a physical
format, i.e., an audio compact disc, the songs used in this study are available from the corre-
sponding authors.
(PDF)
Acknowledgments
The authors wish to thank the children and parents for their participation and the time they
committed to this study and M. Paz Diaz Hue
´lamo for her immediate availability.
Author Contributions
Conceptualization: Alberto Montero-Ruiz, Laura A. Fuentes, Javier Pe
´rez Frı
´as, Elisa Martı
´n-
Montañez.
Data curation: Alberto Montero-Ruiz.
Formal analysis: Nuria Garcı
´a-Agua Soler, Francisca Rius-Diaz, Elisa Martı
´n-Montañez.
Funding acquisition: Alberto Montero-Ruiz, Laura A. Fuentes, Javier Pe
´rez Frı
´as, Elisa Mar-
´n-Montañez.
Investigation: Alberto Montero-Ruiz, Estela Pe
´rez Ruiz, Pilar Caro Aguilera, Elisa Martı
´n-
Montañez.
Methodology: Alberto Montero-Ruiz, Laura A. Fuentes, Nuria Garcı
´a-Agua Soler, Javier
Pe
´rez Frı
´as, Elisa Martı
´n-Montañez.
Project administration: Estela Pe
´rez Ruiz, Javier Pe
´rez Frı
´as, Elisa Martı
´n-Montañez.
Resources: Estela Pe
´rez Ruiz, Pilar Caro Aguilera, Javier Pe
´rez Frı
´as.
Visualization: Nuria Garcı
´a-Agua Soler, Francisca Rius-Diaz, Elisa Martı
´n-Montañez.
Writing original draft: Alberto Montero-Ruiz, Javier Pe
´rez Frı
´as, Elisa Martı
´n-Montañez.
Writing review & editing: Alberto Montero-Ruiz, Laura A. Fuentes, Estela Pe
´rez Ruiz,
Nuria Garcı
´a-Agua Soler, Francisca Rius-Diaz, Pilar Caro Aguilera, Javier Pe
´rez Frı
´as, Elisa
Martı
´n-Montañez.
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 12 / 15
References
1. O’Sullivan BP, Freedman SD. Cystic fibrosis. Lancet. 2009; 373: 1891–1904. https://doi.org/10.1016/
S0140-6736(09)60327-5 PMID: 19403164
2. Adler FR, Liou TG. The Dynamics of Disease Progression in Cystic Fibrosis. Omri A, editor. PLoS One.
Public Library of Science; 2016; 11: e0156752. https://doi.org/10.1371/journal.pone.0156752 PMID:
27248696
3. Brown SD, White R, Tobin P. Keep them breathing: Cystic fibrosis pathophysiology, diagnosis, and
treatment. JAAPA. 2017; 30: 23–27. https://doi.org/10.1097/01.JAA.0000515540.36581.92 PMID:
28441669
4. Warnock L, Gates A. Chest physiotherapy compared to no chest physiotherapy for cystic fibrosis.
Cochrane database Syst Rev. 2015; CD001401. https://doi.org/10.1002/14651858.CD001401.pub3
PMID: 26688006
5. Wilson LM, Morrison L, Robinson KA. Airway clearance techniques for cystic fibrosis: an overview of
Cochrane systematic reviews. Cochrane database Syst Rev. 2019; 1: CD011231. https://doi.org/10.
1002/14651858.CD011231.pub2 PMID: 30676656
6. Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: what
gets in the way? J Pediatr Psychol. 2006; 31: 846–58. https://doi.org/10.1093/jpepsy/jsj096 PMID:
16401680
7. Goodfellow NA, Hawwa AF, Reid AJ, Horne R, Shields MD, McElnay JC. Adherence to treatment in
children and adolescents with cystic fibrosis: a cross-sectional, multi-method study investigating the
influence of beliefs about treatment and parental depressive symptoms. BMC Pulm Med. 2015; 15: 43.
https://doi.org/10.1186/s12890-015-0038-7 PMID: 25927329
8. Quittner AL, Saez-Flores E, Barton JD. The psychological burden of cystic fibrosis. Curr Opin Pulm
Med. 2016; 22: 187–91. https://doi.org/10.1097/MCP.0000000000000244 PMID: 26814144
9. Bausewein C, Booth S, Gysels M, Higginson IJ. Non-pharmacological interventions for breathlessness
in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev. John
Wiley & Sons, Ltd; 2013; https://doi.org/10.1002/14651858.CD005623.pub3 PMID: 24272974
10. Canga B, Azoulay R, Raskin J, Loewy J. AIR: Advances in Respiration–Music therapy in the treatment
of chronic pulmonary disease. Respir Med. W.B. Saunders; 2015; 109: 1532–1539. https://doi.org/10.
1016/j.rmed.2015.10.001 PMID: 26522499
11. Kaak I, Helbig I AT. Didgeridoo playing as an adjunctive therapy to conventional physiotherapy for
patients with cystic fibrosisNo Title. Zeitschrift fu¨r Physiother. 2011; 63: 6–14.
12. Irons JY, Kuipers K, Petocz P. Exploring the health benefits of signing for young people with cystic fibro-
sis. Int J Ther Rehabil. 2014; 20: 144–153. https://doi.org/10/12968/ijtr.2013.20.3.144
13. Irons JY, Kenny DT, McElrea M, Chang AB. Singing Therapy for Young People With Cystic Fibrosis: A
Randomized Controlled Pilot Study. Music Med. 2012; 4: 136–145. https://doi.org/10.1177/
1943862112452150
14. Grasso MC, Button BM, Allison DJ, Sawyer SM. Benefits of music therapy as an adjunct to chest phys-
iotherapy in infants and toddlers with cystic fibrosis. Pediatr Pulmonol. John Wiley & Sons, Ltd; 2000;
29: 371–381. https://doi.org/10.1002/(sici)1099-0496(200005)29:5<371::aid-ppul6>3.0.co;2-k PMID:
10790249
15. Calik-Kutukcu E, Saglam M, Vardar-Yagli N, Cakmak A, Inal-Ince D, Bozdemir-Ozel C, et al. Listening
to motivational music while walking elicits more positive affective response in patients with cystic fibro-
sis. Complement Ther Clin Pract. Churchill Livingstone; 2016; 23: 52–58. https://doi.org/10.1016/j.ctcp.
2016.03.002 PMID: 27157959
16. Smyth AR, Bell SC, Bojcin S, Bryon M, Duff A, Flume P, et al. European cystic fibrosis society standards
of care: Best practice guidelines. J Cyst Fibros. European Cystic Fibrosis Society.; 2014; 13: S23–S42.
https://doi.org/10.1016/j.jcf.2014.03.010 PMID: 24856775
17. Alexander S, Alshafi K, Anderson A-K, Balfour-Lynn I, Bentley S, Buchdahl R, et al. Royal Brompton &
Harefield Clinical Guidelines: Care of Children with Cystic Fibrosis. R Brompt Hosp ( 7th Ed 2017 www.
rbht.nhs.uk/childrencf (cited 07 Febr 2017). 2017; Available: www.rbht.nhs.uk/childrencf.
18. Loyola Elizondo E SALHVXSPMVFECSC. EPIDAT. In: Galician Health Service website [Internet].
2006. Available: https://www.sergas.es/Saude-publica/EPIDAT.
19. Nordoff P, Robbins C. Music therapy in special education. Barcelona Publishers; 2006. https://doi.org/
10.1177/1359104506061418 PMID: 17086688
20. Ferna
´ndez Batanero JM CFJ. Music therapy and social integration in juvenile offenders. A case study.
educational profiles, 38. 2016. pp. 163–180.
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 13 / 15
21. Ministry of Health, Social Services and Equality. Analysis and development of the DRGs in the National
Health System. [Internet]. [cited 13 Apr 2019]. Available: www.mscbs.gob.es/estadEstudios/
estadisticas/inforRecopilaciones/anaDesarrolloGDR.htm.
22. Albi G, Rayo
´n-Aledo JC, Caballero P, Rosado P, Garcı
´a-Esparza E. Cystic fibrosis in images: the
Bhalla scoring system for computed tomography in paediatric patients. Radiologia. 2012; 54: 260–268.
https://doi.org/10.1016/j.rx.2011.04.007 PMID: 21940023
23. Sawicki GS, Heller KS, Demars N, Robinson WM. Motivating adherence among adolescents with cystic
fibrosis: youth and parent perspectives. Pediatr Pulmonol. 2015; 50: 127–36. https://doi.org/10.1002/
ppul.23017 PMID: 24616259
24. Nicolais CJ, Bernstein R, Saez-Flores E, McLean KA, Riekert KA, Quittner AL. Identifying Factors that
Facilitate Treatment Adherence in Cystic Fibrosis: Qualitative Analyses of Interviews with Parents and
Adolescents. J Clin Psychol Med Settings. 2019; https://doi.org/10.1007/s10880-018-9598-z PMID:
30790101
25. Smith BA, Modi AC, Quittner AL, Wood BL. Depressive symptoms in children with cystic fibrosis and
parents and its effects on adherence to airway clearance. Pediatr Pulmonol. 2010; 45: 756–63. https://
doi.org/10.1002/ppul.21238 PMID: 20597082
26. Dębska M, Polechoński J, Mynarski A, Polechoński P. Enjoyment and intensity of physical activity in
immersive virtual reality performed on innovative training devices in compliance with recommendations
for health. Int J Environ Res Public Health. MDPI AG; 2019; 16. https://doi.org/10.3390/ijerph16193673
PMID: 31574911
27. McNamara RJ, McKeough ZJ, McKenzie DK, Alison JA. Acceptability of the aquatic environment for
exercise training by people with chronic obstructive pulmonary disease with physical comorbidities:
Additional results from a randomised controlled trial. Physiotherapy. 2015; 101: 187–92. https://doi.org/
10.1016/j.physio.2014.09.002 PMID: 25544594
28. McNamara RJ, Dale M, McKeough ZJ. Innovative strategies to improve the reach and engagement in
pulmonary rehabilitation. J Thorac Dis. 2019; 11: S2192–S2199. https://doi.org/10.21037/jtd.2019.10.
29 PMID: 31737346
29. Ho CF, Maa SH, Shyu YIL, Lai Y Te, Hung TC, Chen HC. Effectiveness of paced walking to music at
home for patients with COPD. COPD J Chronic Obstr Pulm Dis. 2012; 9: 447–457. https://doi.org/10.
3109/15412555.2012.685664 PMID: 22643033
30. Lord VM, Hume VJ, Kelly JL, Cave P, Silver J, Waldman M, et al. Singing classes for chronic obstructive
pulmonary disease: a randomized controlled trial. BMC Pulm Med. 2012; 12: 69. https://doi.org/10.
1186/1471-2466-12-69 PMID: 23145504
31. Skingley A, Clift S, Hurley S, Price S, Stephens L. Community singing groups for people with chronic
obstructive pulmonary disease: participant perspectives. Perspect Public Health. 2018; 138: 66–75.
https://doi.org/10.1177/1757913917740930 PMID: 29160737
32. Juslin PN, Laukka P. Expression, Perception, and Induction of Musical Emotions: A Review and a
Questionnaire Study of Everyday Listening. J New Music Res. Taylor & Francis Group; 2004; 33: 217–
238. https://doi.org/10.1080/0929821042000317813
33. Garcia Sanz E. Music therapy and personal enrichment. Rev Interuniv Form del Profr. Asociacio
´n Uni-
versitaria de Formacio
´n del Profesorado; 1989; 91–108. Available: https://dialnet.unirioja.es/servlet/
articulo?codigo = 117616.
34. Alvin J. Music Therapy. Paido
´s Ibe
´rica; 1997.
35. Pino M. Reflections on Music and Neuroscience. Rev Med y humanidades. 2011; 3: 42–50. Available:
https://maustike.wordpress.com/2017/02/19/reflexiones-sobre-musica-y-neurociencia/.
36. Gagnon L, Peretz I. Mode and tempo relative contributions to &quot;happy-sad&quot; judgements in
equitone melodies. Cogn Emot. 2003; 17: 25–40. https://doi.org/10.1080/02699930302279 PMID:
29715736
37. Ka
´rolyi O, Paniagua C. Introducing music [Internet]. Alianza Editorial; 2012. Available: https://www.
elargonauta.com/libros/introduccion-a-la-musica/978-84-206-0850-1/.
38. Cassidy JW. The effect of decibel level of music stimuli and gender on head circumference and physio-
logical responses of premature infants in the NICU. J Music Ther. 2009; 46: 180–90. Available: http://
www.ncbi.nlm.nih.gov/pubmed/19757874.https://doi.org/10.1093/jmt/46.3.180 PMID: 19757874
39. Malone AB. The Effects of Live Music on the Distress of Pediatric Patients Receiving Intravenous
Starts, Venipunctures, Injections, and Heel Sticks. J Music Ther. Narnia; 1996; 33: 19–33. https://doi.
org/10.1093/jmt/33.1.19
40. Marwah N, Prabhakar A, Raju O. Music distraction—its efficacy in management of anxious pediatric
dental patients. J Indian Soc Pedod Prev Dent. Medknow Publications; 2005; 23: 168. https://doi.org/
10.4103/0970-4388.19003 PMID: 16327136
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 14 / 15
41. Noguchi LK. The effect of music versus nonmusic on behavioral signs of distress and self-report of pain
in pediatric injection patients. J Music Ther. 2006; 43: 16–38. Available: http://www.ncbi.nlm.nih.gov/
pubmed/16671836.https://doi.org/10.1093/jmt/43.1.16 PMID: 16671836
42. Hartling L, Newton AS, Liang Y, Jou H, Hewson K, Klassen TP, et al. Music to Reduce Pain and Dis-
tress in the Pediatric Emergency Department. JAMA Pediatr. American Medical Association; 2013;
167: 826. https://doi.org/10.1001/jamapediatrics.2013.200 PMID: 23857075
43. Calcaterra V, Ostuni S, Bonomelli I, Mencherini S, Brunero M, Zambaiti E, et al. Music benefits on post-
operative distress and pain in pediatric day care surgery. Pediatr Rep. 2014; 6: 5534. https://doi.org/10.
4081/pr.2014.5534 PMID: 25635217
44. Sepu
´lveda-Vildo
´sola AC, Herrera-Zaragoza OR, Jaramillo-Villanueva L, Anaya-Segura A. Music as an
adjuvant treatment for anxiety in pediatric oncologic patients. Rev Med Inst Mex Seguro Soc. 2014; 52
Suppl 2: S50–4. Available: http://www.ncbi.nlm.nih.gov/pubmed/24983556. PMID: 24983556
45. Caparros-Gonzalez RA, de la Torre-Luque A, Diaz-Piedra C, Vico FJ, Buela-Casal G. Listening to
Relaxing Music Improves Physiological Responses in Premature Infants. Adv Neonatal Care. 2018; 18:
58–69. https://doi.org/10.1097/ANC.0000000000000448 PMID: 29045255
46. Panigrahi A, Sohani S, Amadi C, Joshi A. Role of music in the management of chronic obstructive pul-
monary disease (COPD): A literature review. Technol Heal Care. IOS Press; 2014; 22: 53–61. https://
doi.org/10.3233/THC-130773 PMID: 24398814
47. Bauldoff GS, Hoffman LA, Zullo TG, Sciurba FC. Exercise maintenance following pulmonary rehabilita-
tion: effect of distractive stimuli. Chest. 2002; 122: 948–54. https://doi.org/10.1378/chest.122.3.948
PMID: 12226037
48. Bauldoff GS, Rittinger M, Nelson T, Doehrel J, Diaz PT. Feasibility of distractive auditory stimuli on
upper extremity training in persons with chronic obstructive pulmonary disease. J Cardiopulm Rehabil.
25: 50–5. https://doi.org/10.1097/00008483-200501000-00011 PMID: 15714113
49. Chest Physical Therapy | CF Foundation [Internet]. [cited 8 May 2019]. Available: https://www.cff.org/
Life-With-CF/Treatments-and-Therapies/Airway-Clearance/Chest-Physical-Therapy/.
50. Wade LM. A Comparison of the Effects of Vocal Exercises/Singing Versus Music-Assisted Relaxation
on Peak Expiratory Flow Rates of Children with Asthma. Music Ther Perspect. Narnia; 2002; 20: 31–37.
https://doi.org/10.1093/mtp/20.1.31
51. Konstan MW, Wagener JS, Yegin A, Millar SJ, Pasta DJ, VanDevanter DR. Design and powering of
cystic fibrosis clinical trials using rate of FEV1 decline as an efficacy endpoint. J Cyst Fibros. 2010;
9:332–338. https://doi.org/10.1016/j.jcf.2010.05.004 PMID: 20646968
52. Szczesniak R, Heltshe SL, Stanojevic S, Mayer-Hamblett N. Use of FEV1 in cystic fibrosis epidemio-
logic studies and clinical trials: A statistical perspective for the clinical researcher. J Cyst Fibros. 2017;
16: 318–326. https://doi.org/10.1016/j.jcf.2017.01.002 PMID: 28117136
53. Downs JA, Roberts CM, Blackmore AM, Le Souef PN, Jenkins SC. Benefits of an education programme
on the self-management of aerosol and airway. Chron Respir Dis. 2006; 3: 19–27. https://doi.org/10.
1191/1479972306cd100oa PMID: 16509174
54. Zanni RL, Sembrano EU, Du DT, Marra B, Bantang R. The impact of re-education of airway clearance
techniques (REACT) on adherence and pulmonary function in patients with cystic fibrosis. BMJ Qual
Saf. BMJ Publishing Group; 2014; 23. https://doi.org/10.1136/bmjqs-2013-002352 PMID: 24608551
PLOS ONE
Cystic fibrosis: Chest physiotherapy and music therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0241334 October 30, 2020 15 / 15
Article
Background: Cystic fibrosis (CF) is a life-limiting genetic disorder predominantly affecting the lungs and pancreas. Airway clearance techniques (ACTs) and exercise therapy are key components of physiotherapy, which is considered integral in managing CF; however, low adherence is well-documented. Poor physiotherapy adherence may lead to repeated respiratory infections, reduced exercise tolerance, breathlessness, reduced quality of life, malaise and reduced life expectancy, as well as increased use of pharmacology, healthcare access and hospital admission. Therefore, evidence-based strategies to inform clinical practice and improve adherence to physiotherapy may improve quality of life and reduce treatment burden. Objectives: To assess the effects of interventions to enhance adherence to airway clearance treatment and exercise therapy in people with CF and their effects on health outcomes, such as pulmonary exacerbations, exercise capacity and health-related quality of life. Search methods: We searched the Cochrane Cystic Fibrosis Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books. Date of last search: 1 March 2023. We also searched online trials registries and the reference lists of relevant articles and reviews. Date of last search: 28 March 2023. Selection criteria: We included randomised controlled trials (RCTs) and quasi-RCTs of parallel design assessing any intervention aimed at enhancing adherence to physiotherapy in people with CF versus no intervention, another intervention or usual care. Data collection and analysis: Two review authors independently checked search results for eligible studies and independently extracted data. We used standard procedures recommended by Cochrane and assessed the certainty of evidence using the GRADE system. Main results: Two RCTs (77 participants with CF; age range 2 to 20 years; 44 (57%) males) met the inclusion criteria of this review. One study employed an intervention to improve adherence to exercise and the second an intervention to improve adherence to ACT. Both studies measured outcomes at baseline and at three months, but neither study formally assessed our primary outcome of adherence in terms of our planned outcome measures, and results were dependent on self-reported data. Adherence to ACTs One RCT (43 participants) assessed using specifically-composed music alongside ACTs compared to self-selected or no music (usual care). The ACT process consisted of nebuliser inhalation treatment, ACTs and relaxation or antibiotic nebuliser treatment. We graded all evidence as very low certainty. This study reported adherence to ACTs using the Morisky-Green questionnaire and also participants' perception of treatment time and enjoyment, which may influence adherence (outcome not reported specifically in this review). We are uncertain whether participants who received specifically-composed music may be more likely to adhere at six and 12 weeks compared to those who received usual care, risk ratio (RR) 1.75 (95% confidence interval (CI) 1.07 to 2.86) and RR 1.56 (95% CI 1.01 to 2.40) respectively. There may not be any difference in adherence when comparing specifically-composed music to self-selected music at six weeks, RR 1.21 (95% CI 0.87 to 1.68) or 12 weeks, RR 1.52 (95% CI 0.97 to 2.38); or self-selected music to usual care at six weeks, RR 1.44 (95% CI 0.82 to 2.52) or 12 weeks, RR 1.03 (95% CI 0.57 to 1.86). The music study also reported the number of respiratory infections requiring hospitalisation at 12 weeks, with no difference seen in the risk of hospitalisation between all groups. Adherence to exercise One RCT (24 participants) compared the provision of a manual of aerobic exercises, recommended exercise prescription plus two-weekly follow-up phone calls to reinforce exercise practice over a period of three months to verbal instructions for aerobic exercise according to the CF centre's protocol. We graded all evidence as very low certainty. We are uncertain whether an educational intervention leads to more participants in the intervention group undertaking increased regular physical activity at three months (self-report), RR 3.67 (95% CI 1.24 to 10.85), and there was no reported difference between groups in the number undertaking physical activity three times per week or undertaking at least 40 minutes of physical activity. No effect was seen on secondary outcome measures of spirometry, exercise capacity or any CF quality of life domains. This study did not report on the frequency of respiratory infections (hospitalised or not) or adverse events. Authors' conclusions: We are uncertain whether a music-based motivational intervention may increase adherence to ACTs or affect the risk of hospitalisation for a respiratory infection. We are also uncertain whether an educational intervention increases adherence to exercise or reduces the frequency of respiratory infection-related hospital admission. However, these results are largely based on self-reported data and the impact of strategies to improve adherence to ACT and exercise in children and adolescents with stable CF remains inconclusive. Given that adherence to ACT and exercise therapy are fundamental to the clinical management of people with CF, there is an urgent need for well-designed, large-scale clinical trials in this area, which should conform to the CONSORT statement for standards of reporting and use appropriate, validated outcome measures. Studies should also ensure full disclosure of data for all important clinical outcomes.
Article
Background: Despite evidence of the long-term implications of unrelieved pain during infancy, it is evident that infant pain is still under-managed and unmanaged. Inadequately managed pain in infancy, a period of exponential development, can have implications across the lifespan. Therefore, a comprehensive and systematic review of pain management strategies is integral to appropriate infant pain management. This is an update of a previously published review update in the Cochrane Database of Systematic Reviews (2015, Issue 12) of the same title. Objectives: To assess the efficacy and adverse events of non-pharmacological interventions for infant and child (aged up to three years) acute pain, excluding kangaroo care, sucrose, breastfeeding/breast milk, and music. Search methods: For this update, we searched CENTRAL, MEDLINE-Ovid platform, EMBASE-OVID platform, PsycINFO-OVID platform, CINAHL-EBSCO platform and trial registration websites (ClinicalTrials.gov; International Clinical Trials Registry Platform) (March 2015 to October 2020). An update search was completed in July 2022, but studies identified at this point were added to 'Awaiting classification' for a future update. We also searched reference lists and contacted researchers via electronic list-serves. We incorporated 76 new studies into the review. SELECTION CRITERIA: Participants included infants from birth to three years in randomised controlled trials (RCTs) or cross-over RCTs that had a no-treatment control comparison. Studies were eligible for inclusion in the analysis if they compared a non-pharmacological pain management strategy to a no-treatment control group (15 different strategies). In addition, we also analysed studies when the unique effect of adding a non-pharmacological pain management strategy onto another pain management strategy could be assessed (i.e. additive effects on a sweet solution, non-nutritive sucking, or swaddling) (three strategies). The eligible control groups for these additive studies were sweet solution only, non-nutritive sucking only, or swaddling only, respectively. Finally, we qualitatively described six interventions that met the eligibility criteria for inclusion in the review, but not in the analysis. DATA COLLECTION AND ANALYSIS: The outcomes assessed in the review were pain response (reactivity and regulation) and adverse events. The level of certainty in the evidence and risk of bias were based on the Cochrane risk of bias tool and the GRADE approach. We analysed the standardised mean difference (SMD) using the generic inverse variance method to determine effect sizes. MAIN RESULTS: We included total of 138 studies (11,058 participants), which includes an additional 76 new studies for this update. Of these 138 studies, we analysed 115 (9048 participants) and described 23 (2010 participants) qualitatively. We described qualitatively studies that could not be meta-analysed due to being the only studies in their category or statistical reporting issues. We report the results of the 138 included studies here. An SMD effect size of 0.2 represents a small effect, 0.5 a moderate effect, and 0.8 a large effect. The thresholds for the I2 interpretation were established as follows: not important (0% to 40%); moderate heterogeneity (30% to 60%); substantial heterogeneity (50% to 90%); considerable heterogeneity (75% to 100%). The most commonly studied acute procedures were heel sticks (63 studies) and needlestick procedures for the purposes of vaccines/vitamins (35 studies). We judged most studies to have high risk of bias (103 out of 138), with the most common methodological concerns relating to blinding of personnel and outcome assessors. Pain responses were examined during two separate pain phases: pain reactivity (within the first 30 seconds after the acutely painful stimulus) and immediate pain regulation (after the first 30 seconds following the acutely painful stimulus). We report below the strategies with the strongest evidence base for each age group. In preterm born neonates, non-nutritive sucking may reduce pain reactivity (SMD -0.57, 95% confidence interval (CI) -1.03 to -0.11, moderate effect; I2 = 93%, considerable heterogeneity) and improve immediate pain regulation (SMD -0.61, 95% CI -0.95 to -0.27, moderate effect; I2 = 81%, considerable heterogeneity), based on very low-certainty evidence. Facilitated tucking may also reduce pain reactivity (SMD -1.01, 95% CI -1.44 to -0.58, large effect; I2 = 93%, considerable heterogeneity) and improve immediate pain regulation (SMD -0.59, 95% CI -0.92 to -0.26, moderate effect; I2 = 87%, considerable heterogeneity); however, this is also based on very low-certainty evidence. While swaddling likely does not reduce pain reactivity in preterm neonates (SMD -0.60, 95% CI -1.23 to 0.04, no effect; I2 = 91%, considerable heterogeneity), it has been shown to possibly improve immediate pain regulation (SMD -1.21, 95% CI -2.05 to -0.38, large effect; I2 = 89%, considerable heterogeneity), based on very low-certainty evidence. In full-term born neonates, non-nutritive sucking may reduce pain reactivity (SMD -1.13, 95% CI -1.57 to -0.68, large effect; I2 = 82%, considerable heterogeneity) and improve immediate pain regulation (SMD -1.49, 95% CI -2.20 to -0.78, large effect; I2 = 92%, considerable heterogeneity), based on very low-certainty evidence. In full-term born older infants, structured parent involvement was the intervention most studied. Results showed that this intervention has little to no effect in reducing pain reactivity (SMD -0.18, 95% CI -0.40 to 0.03, no effect; I2 = 46%, moderate heterogeneity) or improving immediate pain regulation (SMD -0.09, 95% CI -0.40 to 0.21, no effect; I2 = 74%, substantial heterogeneity), based on low- to moderate-certainty evidence. Of these five interventions most studied, only two studies observed adverse events, specifically vomiting (one preterm neonate) and desaturation (one full-term neonate hospitalised in the NICU) following the non-nutritive sucking intervention. The presence of considerable heterogeneity limited our confidence in the findings for certain analyses, as did the preponderance of evidence of very low to low certainty based on GRADE judgements. Authors' conclusions: Overall, non-nutritive sucking, facilitated tucking, and swaddling may reduce pain behaviours in preterm born neonates. Non-nutritive sucking may also reduce pain behaviours in full-term neonates. No interventions based on a substantial body of evidence showed promise in reducing pain behaviours in older infants. Most analyses were based on very low- or low-certainty grades of evidence and none were based on high-certainty evidence. Therefore, the lack of confidence in the evidence would require further research before we could draw a definitive conclusion.
Article
Full-text available
Background: Adherence to treatment, including inhaled therapies, is low in people with cystic fibrosis (CF). Although psychological interventions for improving adherence to inhaled therapies in people with CF have been developed, no previous published systematic review has evaluated the evidence for efficacy of these interventions. Objectives: The primary objective of the review was to assess the efficacy of psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis (CF). The secondary objective was to establish the most effective components, or behaviour change techniques (BCTs), used in these interventions. Search methods: We searched the Cochrane Cystic Fibrosis Trials Register, which is compiled from electronic database searches and handsearching of journals and conference abstract books. We also searched databases (PubMed; PsycINFO; EBSCO; Scopus; OpenGrey), trials registries (World Health Organization International Clinical Trials Registry Platform; US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov), and the reference lists of relevant articles and reviews, with no restrictions on language, year or publication status. Date of search: 7 August 2022. Selection criteria: We included randomised controlled trials (RCTs) comparing different types of psychological interventions for improving adherence to inhaled therapies in people with CF of any age, or comparing psychological interventions with usual care. We included quasi-RCTs if we could reasonably assume that the baseline characteristics were similar in both groups. Data collection and analysis: Two review authors independently assessed trial eligibility and completed data extraction, risk of bias assessments, and BCT coding (using the BCT Taxonomy v1) for all included trials. We resolved any discrepancies by discussion, or by consultation with a third review author as necessary. We assessed the certainty of the evidence using GRADE. Main results: We included 10 trials (1642 participants) in the review (children and adolescents in four trials; adults in five trials; and children and adults in one trial). Nine trials compared a psychological intervention with usual care; we could combine data from some of these in a number of quantitative analyses. One trial compared a psychological intervention with an active comparator (education plus problem-solving (EPS)). We identified five ongoing trials. Psychological interventions were generally multi-component and complex, containing an average of 9.6 BCTs (range 1 to 28). The two most commonly used BCTs included 'problem-solving' and 'instruction on how to perform the behaviour'. Interventions varied in their type, content and mode of delivery. They included a problem-solving intervention; a paper-based self-management workbook; a telehealth intervention; a group training programme; a digital intervention comprising medication reminders and lung function self-monitoring; a life-coaching intervention; a motivational interviewing (MI) intervention; a brief MI intervention (behaviour change counselling); and a digital intervention combined with behaviour change sessions. Intervention duration ranged from 10 weeks to 12 months. Assessment time points ranged from six to eight weeks up to 23 months. Psychological interventions compared with usual care We report data here for the 'over six months and up to 12 months' time point. We found that psychological interventions probably improve adherence to inhaled therapies (primary outcome) in people with CF compared with usual care (mean difference (MD) 9.5, 95% confidence interval (CI) 8.60 to 10.40; 1 study, 588 participants; moderate-certainty evidence). There was no evidence of a difference between groups in our second primary outcome, treatment-related adverse events: anxiety (MD 0.30, 95% CI -0.40 to 1.00; 1 study, 535 participants), or depression (MD -0.10, 95% CI -0.80 to 0.60; 1 study, 534 participants), although this was low-certainty evidence. For our secondary outcomes, there was no evidence of a difference between groups in terms of lung function (forced expiratory volume in one second (FEV1) % predicted MD 1.40, 95% CI -0.20 to 3.00; 1 study, 556 participants; moderate-certainty evidence); number of pulmonary exacerbations (adjusted rate ratio 0.96, 95% CI 0.83 to 1.11; 1 study, 607 participants; moderate-certainty evidence); or respiratory symptoms (MD 0.70, 95% CI -2.40 to 3.80; 1 study, 534 participants; low-certainty evidence). However, psychological interventions may improve treatment burden (MD 3.90, 95% CI 1.20 to 6.60; 1 study, 539 participants; low-certainty evidence). The overall certainty of the evidence ranged from low to moderate across these outcomes. Reasons for downgrading included indirectness (current evidence included adults only whereas our review question was broader and focused on people of any age) and lack of blinding of outcome assessors. Psychological interventions compared with an active comparator For this comparison the overall certainty of evidence was very low, based on one trial (n = 128) comparing an MI intervention to EPS for 12 months. We are uncertain whether an MI intervention, compared with EPS, improves adherence to inhaled therapies, lung function, or quality of life in people with CF, or whether there is an effect on pulmonary exacerbations. The included trial for this comparison did not report on treatment-related adverse events (anxiety and depression). We downgraded all reported outcomes due to small participant numbers, indirectness (trials included only adults), and unclear risk of bias (e.g. selection and attrition bias). Authors' conclusions: Due to the limited quantity of trials included in this review, as well as the clinical and methodological heterogeneity, it was not possible to identify an overall intervention effect using meta-analysis. Some moderate-certainty evidence suggests that psychological interventions (compared with usual care) probably improve adherence to inhaled therapies in people with CF, without increasing treatment-related adverse events, anxiety and depression (low-certainty evidence). In future review updates (with ongoing trial results included), we hope to be able to establish the most effective BCTs (or 'active ingredients') of interventions for improving adherence to inhaled therapies in people with CF. Wherever possible, investigators should make use of the most objective measures of adherence available (e.g. data-logging nebulisers) to accurately determine intervention effects. Outcome reporting needs to be improved to enable combining or separation of measures as appropriate. Likewise, trial reporting needs to include details of intervention content (e.g. BCTs used); duration; intensity; and fidelity. Large trials with a longer follow-up period (e.g. 12 months) are needed in children with CF. Additionally, more research is needed to determine how to support adherence in 'under-served' CF populations.
Article
Full-text available
Objective: Hospitalization and the possibility of surgery are known as the main causes of anxiety in children, and anxiety is a natural physiological process in individuals that allows them to adapt and deal with a diversity of adverse conditions. The purpose of this research aimed to compare 2 methods of distraction including puzzle-solving and music on anxiety before pediatric surgery. Materials and methods: This study is clinical trial research. First, 90 children 6 to 10 years old were randomly assigned to the intervention and control groups. In group A, the visual puzzlesolving items were presented, in group B, music with related pictures via a tablet was presented in the waiting room for surgery, and in group C, only standard care for each patient was presented. Anxiety before surgery was measured with a Children's Fear Scale questionnaire before moving the patient to the operating room, then 30 minutes before surgery in the pre-surgery waiting room, and the third stage immediately after transfer to the operating room before induction of anesthesia. Data were analyzed by one-way analysis of variance, chi-square test, and Tukey test using Statistical Package for the Social Sciences software version 21.0. Results: The results of this research showed that the levels of anxiety significantly improved in the intervention groups compared to the control group after the intervention (P < .001). Conclusion: Music and puzzle-solving as complementary therapy can improve the levels of anxiety in children before surgery. Therefore, this technique can be recommended to be used along with modern medicine in children.
Article
Background: Physical activity (including exercise) may form an important part of regular care for people with cystic fibrosis (CF). This is an update of a previously published review. Objectives: To assess the effects of physical activity interventions on exercise capacity by peak oxygen uptake, lung function by forced expiratory volume in one second (FEV1), health-related quality of life (HRQoL) and further important patient-relevant outcomes in people with cystic fibrosis (CF). Search methods: We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register which comprises references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. The most recent search was on 3 March 2022. We also searched two ongoing trials registers: clinicaltrials.gov, most recently on 4 March 2022; and the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP), most recently on 16 March 2022. SELECTION CRITERIA: We included all randomised controlled trials (RCTs) and quasi-RCTs comparing physical activity interventions of any type and a minimum intervention duration of two weeks with conventional care (no physical activity intervention) in people with CF. Data collection and analysis: Two review authors independently selected RCTs for inclusion, assessed methodological quality and extracted data. We assessed the certainty of the evidence using GRADE. MAIN RESULTS: We included 24 parallel RCTs (875 participants). The number of participants in the studies ranged from nine to 117, with a wide range of disease severity. The studies' age demographics varied: in two studies, all participants were adults; in 13 studies, participants were 18 years and younger; in one study, participants were 15 years and older; in one study, participants were 12 years and older; and seven studies included all age ranges. The active training programme lasted up to and including six months in 14 studies, and longer than six months in the remaining 10 studies. Of the 24 included studies, seven implemented a follow-up period (when supervision was withdrawn, but participants were still allowed to exercise) ranging from one to 12 months. Studies employed differing levels of supervision: in 12 studies, training was supervised; in 11 studies, it was partially supervised; and in one study, training was unsupervised. The quality of the included studies varied widely. This Cochrane Review shows that, in studies with an active training programme lasting over six months in people with CF, physical activity probably has a positive effect on exercise capacity when compared to no physical activity (usual care) (mean difference (MD) 1.60, 95% confidence interval (CI) 0.16 to 3.05; 6 RCTs, 348 participants; moderate-certainty evidence). The magnitude of improvement in exercise capacity is interpreted as small, although study results were heterogeneous. Physical activity interventions may have no effect on lung function (forced expiratory volume in one second (FEV1) % predicted) (MD 2.41, 95% CI ‒0.49 to 5.31; 6 RCTs, 367 participants), HRQoL physical functioning (MD 2.19, 95% CI ‒3.42 to 7.80; 4 RCTs, 247 participants) and HRQoL respiratory domain (MD ‒0.05, 95% CI ‒3.61 to 3.51; 4 RCTs, 251 participants) at six months and longer (low-certainty evidence). One study (117 participants) reported no differences between the physical activity and control groups in the number of participants experiencing a pulmonary exacerbation by six months (incidence rate ratio 1.28, 95% CI 0.85 to 1.94) or in the time to first exacerbation over 12 months (hazard ratio 1.34, 95% CI 0.65 to 2.80) (both high-certainty evidence); and no effects of physical activity on diabetic control (after 1 hour: MD ‒0.04 mmol/L, 95% CI ‒1.11 to 1.03; 67 participants; after 2 hours: MD ‒0.44 mmol/L, 95% CI ‒1.43 to 0.55; 81 participants; moderate-certainty evidence). We found no difference between groups in the number of adverse events over six months (odds ratio 6.22, 95% CI 0.72 to 53.40; 2 RCTs, 156 participants; low-certainty evidence). For other time points (up to and including six months and during a follow-up period with no active intervention), the effects of physical activity versus control were similar to those reported for the outcomes above. However, only three out of seven studies adding a follow-up period with no active intervention (ranging between one and 12 months) reported on the primary outcomes of changes in exercise capacity and lung function, and one on HRQoL. These data must be interpreted with caution. Altogether, given the heterogeneity of effects across studies, the wide variation in study quality and lack of information on clinically meaningful changes for several outcome measures, we consider the overall certainty of evidence on the effects of physical activity interventions on exercise capacity, lung function and HRQoL to be low to moderate. Authors' conclusions: Physical activity interventions for six months and longer likely improve exercise capacity when compared to no training (moderate-certainty evidence). Current evidence shows little or no effect on lung function and HRQoL (low-certainty evidence). Over recent decades, physical activity has gained increasing interest and is already part of multidisciplinary care offered to most people with CF. Adverse effects of physical activity appear rare and there is no reason to actively discourage regular physical activity and exercise. The benefits of including physical activity in an individual's regular care may be influenced by the type and duration of the activity programme as well as individual preferences for and barriers to physical activity. Further high-quality and sufficiently-sized studies are needed to comprehensively assess the benefits of physical activity and exercise in people with CF, particularly in the new era of CF medicine.
Article
Background: There are many accepted airway clearance techniques (ACTs) for managing the respiratory health of people with cystic fibrosis (CF); none of which demonstrate superiority. Other Cochrane Reviews have reported short-term effects related to mucus transport, but no evidence supporting long-term benefits. Exercise is an alternative ACT thought to produce shearing forces within the lung parenchyma, which enhances mucociliary clearance and the removal of viscous secretions. Recent evidence suggests that some people with CF are using exercise as a substitute for traditional ACTs, yet there is no agreed recommendation for this. Additionally, one of the top 10 research questions identified by people with CF is whether exercise can replace other ACTs. Systematically reviewing the evidence for exercise as a safe and effective ACT will help people with CF decide whether to incorporate this strategy into their treatment plans and potentially reduce their treatment burden. The timing of this review is especially pertinent given the shifting landscape of CF management with the advent of highly-effective small molecule therapies, which are changing the way people with CF are cared for. Objectives: To compare the effect of exercise to other ACTs for improving respiratory function and other clinical outcomes in people with CF and to assess the potential adverse effects associated with this ACT. Search methods: On 28 February 2022, we searched the Cochrane Cystic Fibrosis Trials Register, compiled from electronic database searches and handsearching of journals and conference abstract books. We also searched the reference lists of relevant articles and reviews. We searched online clinical trial registries on 15 February 2022. We emailed authors of studies awaiting classification or potentially eligible abstracts for additional information on 1 February 2021. Selection criteria: We selected randomised controlled studies (RCTs) and quasi-RCTs comparing exercise to another ACT in people with CF for at least two treatment sessions. Data collection and analysis: Two review authors independently extracted data and assessed risk of bias for the included studies. They assessed the certainty of the evidence using GRADE. Review authors contacted investigators for further relevant information regarding their publications. Main results: We included four RCTs. The 86 participants had a wide range of disease severity (forced expiratory volume in one second (FEV1) ranged from 54% to 95%) and were 7 to 41 years old. Two RCTs were cross-over and two were parallel in design. Participants in one RCT were hospitalised with an acute respiratory exacerbation, whilst the participants in three RCTs were clinically stable. All four RCTs compared exercise either alone or in combination with another ACT, but these were too diverse to allow us to combine results. The certainty of the evidence was very low; we downgraded it due to low participant numbers and high or unclear risks of bias across all domains. Exercise versus active cycle of breathing technique (ACBT) One cross-over trial (18 participants) compared exercise alone to ACBT. There was no change from baseline in our primary outcome FEV1, although it increased in the exercise group before returning to baseline after 30 minutes; we are unsure if exercise affected FEV1 as the evidence is very low-certainty. Similar results were seen for other measures of lung function. No adverse events occurred during the exercise sessions (very low-certainty evidence). We are unsure if ACBT was perceived to be more effective or was the preferred ACT (very low-certainty evidence). 24-hour sputum volume was less in the exercise group than with ACBT (secondary outcome). Exercise capacity, quality of life, adherence, hospitalisations and need for additional antibiotics were not reported. Exercise plus postural drainage and percussion (PD&P) versus PD&P only Two trials (55 participants) compared exercise and PD&P to PD&P alone. At two weeks, one trial narratively reported a greater increase in FEV1 % predicted with PD&P alone. At six months, the other trial reported a greater increase with exercise combined with PD&P, but did not provide data for the PD&P group. We are uncertain whether exercise with PD&P improves FEV1 as the certainty of evidence is very low. Other measures of lung function did not show clear evidence of effect. One trial reported no difference in exercise capacity (maximal work rate) after two weeks. No adverse events were reported (1 trial, 17 participants; very low-certainty evidence). Adherence was high, with all PD&P sessions and 96% of exercise sessions completed (1 trial, 17 participants; very low-certainty evidence). There was no difference between groups in 24-hour sputum volume or in the mean duration of hospitalisation, although the six-month trial reported fewer hospitalisations due to exacerbations in the exercise and PD&P group. Quality of life, ACT preference and need for antibiotics were not reported. Exercise versus underwater positive expiratory pressure (uPEP) One trial (13 participants) compared exercise to uPEP (also known as bubble PEP). No adverse events were recorded in either group (very low-certainty evidence). Trial investigators reported that participants perceived exercise as more fatiguing but also more enjoyable than bubble PEP (very low-certainty evidence). There were no differences found in the total weight of sputum collected during treatment sessions. The trial did not report the primary outcomes (FEV1, quality of life, exercise capacity) or the secondary outcomes (other measures of lung function, adherence, need for antibiotics or hospitalisations). Authors' conclusions: As one of the top 10 research questions identified by clinicians and people with CF, it is important to systematically review the literature regarding whether or not exercise is an acceptable and effective ACT, and whether it can replace traditional methods. We identified an insufficient number of trials to conclude whether or not exercise is a suitable alternative ACT, and the diverse design of included trials did not allow for meta-analysis of results. The evidence is very low-certainty, so we are uncertain about the effectiveness of exercise as an ACT. Longer studies examining outcomes that are important to people with CF are required to answer this question.
Article
Full-text available
The aim of the study is to assess the enjoyment and intensity of physical exercise while practicing physical activity (PA) in immersive virtual reality (IVR) using innovative training devices (omni-directional Omni treadmill and Icaros Pro flight simulator). The study also contains the results of subjective research on the usefulness of such a form of PA in the opinion of users. In total, 61 adults (10 women and 51 men) took part in the study. To assess the enjoyment level (EL) Interest/Enjoyment subscale of Intrinsic Motivation Inventory (IMI) was used. Exercise intensity was assessed during 10-min sessions of active video games (AVGs) in IVR based on heart rate (HR). The average enjoyment level during physical exercise in IVR on the tested training devices was high (Omni 5.74 points, Icaros 5.60 points on a 1–7 Likert scale) and differed significantly in favor of PA on Omni. In the opinion of the majority of participants, AVGs in IVR on the tested devices constitute a sufficiently useful form of PA to meet the needs of leisure time activities, and they can even replace some forms of physical effort performed in a classic way. The intensity of PA during games on training devices was at the level recommended for health benefits for 80.55% (Omni) and 50.77% (Icaros Pro) of its duration. Based on the conducted research, it can be assumed that AVGs in IVR using a multi-directional treadmill and a flight simulator can be an effective tool for increasing participation in health-oriented PA.
Article
Full-text available
Cystic fibrosis (CF) is a progressive, genetic disease affecting multiple organ systems. Treatments are complex and take 2–4 h per day. Adherence is 50% or less for pulmonary medications, airway clearance, and enzymes. Prior research has identified demographic and psychological variables associated with better adherence; however, no study has extensively identified facilitators of treatment adherence (e.g., adaptive behaviors and cognitions) in a sample of parents and adolescents. Forty-three participants were recruited from four CF centers as part of a larger measurement study. Participants included 29 parents (72% mothers; 72% Caucasian) and 14 adolescents (ages 11–20, 64% female, 71% Caucasian). Participants completed semi-structured interviews to elicit barriers to adherence. However, facilitators of adherence naturally emerged, therefore indicating need for further exploration. Interviews were audiotaped, transcribed and content-analyzed in NVivo to identify those behaviors and beliefs that facilitated adherence, using a phenomenological analysis. Frequencies of these themes were tabulated. Nine themes emerged, with individual codes subsumed under each. Themes included social support, community support, organizational strategies, “intrinsic characteristics,” combining treatments with pleasurable activity, flexibility, easier or faster treatment, prioritizing treatments, and negative effects of non-adherence. Results demonstrated the importance of identifying strategies that positively affect adherence. Interventions that are strength-focused, build on prior success, and utilize positive models generated by those who have successfully integrated CF treatments into their lives are more likely to be efficacious.
Article
Full-text available
Background: Forced expiratory volume in 1s (FEV1) is an established marker of cystic fibrosis (CF) disease progression that is used to capture clinical course and evaluate therapeutic efficacy. The research community has established FEV1 surveillance data through a variety of observational data sources such as patient registries, and there is a growing pipeline of new CF therapies demonstrated to be efficacious in clinical trials by establishing improvements in FEV1. Results: In this review, we summarize from a statistical perspective the clinical relevance of FEV1 based on its association with morbidity and mortality in CF, its role in epidemiologic studies of disease progression and comparative effectiveness, and its utility in clinical trials. In addition, we identify opportunities to advance epidemiologic research and the clinical development pipeline through further statistical considerations. Conclusions: Our understanding of CF disease course, therapeutics, and clinical care has evolved immensely in the past decades, in large part due to the thoughtful application of rigorous research methods and meaningful clinical endpoints such as FEV1. A continued commitment to conduct research that minimizes the potential for bias, maximizes the limited patient population, and harmonizes approaches to FEV1 analysis while maintaining clinical relevance, will facilitate further opportunities to advance CF care.
Article
Full-text available
In cystic fibrosis, statistical models have been more successful in predicting mortality than the time course of clinical status. We develop a system of partial differential equations that simultaneously track mortality and patient status, with all model parameters estimated from the extensive and carefully maintained database from the Cystic Fibrosis Foundation. Cystic fibrosis is an autosomal recessive disease that leads to loss of lung function, most commonly assessed using the Forced Expiratory Volume in 1 second (FEV1%). This loss results from inflammation secondary to chronic bacterial infections, particularly Pseudomonas aeruginosa, methicillin-sensitive Staphylococcus aureus (MSSA) and members of the virulent Burkholderia complex. The model tracks FEV1% and carriage of these three bacteria over the course of a patient's life. Analysis of patient state changes from year to year reveals four feedback loops: a damaging positive feedback loop between P. aeruginosa carriage and lower FEV1%, negative feedback loops between P. aeruginosa and MSSA and between P. aeruginosa and Burkholderia, and a protective positive feedback loop between MSSA carriage and higher FEV1%. The partial differential equations built from this data analysis accurately capture the life-long progression of the disease, quantify the key role of high annual FEV1% variability in reducing survivorship, the relative unimportance of short-term bacterial interactions for long-term survival, and the potential benefits of eradicating the most harmful bacteria.
Article
Evidence of personal and health-system benefits of pulmonary rehabilitation are undeniable. However, the capacity of traditional centre-based models to both reach and appeal to the intended population of people living with chronic obstructive pulmonary disease (COPD) remains difficult. It is well established that issues with access, suitability, referral, uptake, and attrition exist. Consequently, considerable energy has been invested into exploring innovative alternative modes of rehabilitation in an effort to increase the awareness and appeal, and expand the availability of pulmonary rehabilitation. The process of 'thinking differently' and 'pushing the boundaries' of clinical practice is underway, particularly in the United Kingdom and Australia, where new models of pulmonary rehabilitation are being evaluated. The number one priority is reaching the population of people with COPD and ensuring they are referred to rehabilitation services. Active case-finding in primary care, inviting health professionals and health consumers to pulmonary rehabilitation programs to increase understanding and awareness, and utilizing peer support via patient success stories, are just a few suggestions for increasing awareness of pulmonary rehabilitation. Once referred, engaging the population to complete a program is the next challenge. Marketing, patient co-design, alternative rehabilitation settings and modes of exercise training, use of technology, and focusing on modes which provide patient enjoyment and choice are all potential strategies to target in an effort to broaden the appeal and reduce the high attrition rate of traditional centre-based pulmonary rehabilitation programs. Reaching and engaging the target population in pulmonary rehabilitation is an important first step in people with COPD achieving successful outcomes from rehabilitation.
Article
Background: Cystic fibrosis is a life-limiting genetic condition in which thick mucus builds up in the lungs, leading to infections, inflammation, and eventually, deterioration in lung function. To clear their lungs of mucus, people with cystic fibrosis perform airway clearance techniques daily. There are various airway clearance techniques, which differ in terms of the need for assistance or equipment, and cost. Objectives: To summarise the evidence from Cochrane Reviews on the effectiveness and safety of various airway clearance techniques in people with cystic fibrosis. Methods: For this overview, we included Cochrane Reviews of randomised or quasi-randomised controlled trials (including cross-over trials) that evaluated an airway clearance technique (conventional chest physiotherapy, positive expiratory pressure (PEP) therapy, high-pressure PEP therapy, active cycle of breathing techniques, autogenic drainage, airway oscillating devices, external high frequency chest compression devices and exercise) in people with cystic fibrosis.We searched the Cochrane Database of Systematic Reviews on 29 November 2018.Two review authors independently evaluated reviews for eligibility. One review author extracted data from included reviews and a second author checked the data for accuracy. Two review authors independently graded the quality of reviews using the ROBIS tool. We used the GRADE approach for assessing the overall strength of the evidence for each primary outcome (forced expiratory volume in one second (FEV1), individual preference and quality of life). Main results: We included six Cochrane Reviews, one of which compared any type of chest physiotherapy with no chest physiotherapy or coughing alone and the remaining five reviews included head-to-head comparisons of different airway clearance techniques. All the reviews were considered to have a low risk of bias. However, the individual trials included in the reviews often did not report sufficient information to adequately assess risk of bias. Many trials did not sufficiently report on outcome measures and had a high risk of reporting bias.We are unable to draw definitive conclusions for comparisons of airway clearance techniques in terms of FEV1, except for reporting no difference between PEP therapy and oscillating devices after six months of treatment, mean difference -1.43% predicted (95% confidence interval -5.72 to 2.87); the quality of the body of evidence was graded as moderate. The quality of the body of evidence comparing different airway clearance techniques for other outcomes was either low or very low. Authors' conclusions: There is little evidence to support the use of one airway clearance technique over another. People with cystic fibrosis should choose the airway clearance technique that best meets their needs, after considering comfort, convenience, flexibility, practicality, cost, or some other factor. More long-term, high-quality randomised controlled trials comparing airway clearance techniques among people with cystic fibrosis are needed.
Article
Aim: Chronic obstructive pulmonary disease (COPD) is a major public health issue which is irreversible and progressive, but previous research suggests that singing may have beneficial effects. The aim of this study was to establish the views of participants with COPD taking part in a singing for better breathing programme. Methods: This was a descriptive qualitative study nested within a single-cohort feasibility study which included measures of lung function and wellbeing. Participants ( n = 37) were interviewed following a community singing programme that ran over 10 months in South East England. Results: Findings support those from previous studies regarding the impact of singing on respiratory wellbeing. These included the teaching on breath control, relaxation and the breathing exercises, singing as a means to deflect attention away from breathing problems, leading to increased activity levels and the mutual support for respiratory problems. Beyond the impact on breathing, the singing was also seen as fun, and provided friendship and a 'feel-good' factor which led to motivation to participate in further activities. For some, it was the highlight of the week, and singing together in a group was felt to be central to the benefits experienced. Findings are compared with the quantitative measures within the same study. Conclusion: The majority of participants reported improvements in respiratory symptoms as well as mental and social wellbeing following the programme. The study contributes to the evidence base in supporting and highlighting the consistently positive experiences of a large sample of participants, despite variable outcomes in clinical measures.
Article
Background: Premature infants are exposed to high levels of noise in the neonatal intensive care unit (NICU). Purpose: This study evaluated the effect of a relaxing music therapy intervention composed by artificial intelligence on respiratory rate, systolic and diastolic blood pressure, and heart rate. Methods: A double-blind, randomized, controlled trial was conducted in the NICUs of 2 general public hospitals in Andalusia, Spain. Participants were 17 healthy premature infants, randomly allocated to the intervention group or the control group (silence) at a 1:1 ratio. To be included in the study, the subjects were to be 32 to 36 weeks of gestation at birth (M = 32.33; SD = 1.79) and passed a hearing screening test satisfactorily. The intervention lasted 20 minutes, 3 times a day for 3 consecutive days, while infants were in the incubator. Infants' heart rate, respiratory rate, and blood pressure were assessed before and after each intervention session. Results: After each session, the respiratory rate decreased in the experimental group (main between-groups effect (F 1,13 = 6.73, P = .022, [eta]2partial = 0.34). Across the sessions, the heart rate increased in the control group (main between-groups effect, F1,11 = 5.09, P = .045, [eta]2partial = 0.32). Implications for Research: Future studies can use this music intervention to assess its potential effects in premature infants. Implications for Practice: Nurses can apply the relaxing music intervention presented in this study to ameliorate the impact of the stressful environment on premature infants.
Article
Cystic fibrosis (CF) affects more than 30,000 people in the United States and 80,000 people worldwide. This life-threatening genetic disorder causes a buildup of thick, viscous mucus secretions in various organ systems, most commonly the gastrointestinal, pulmonary, and genitourinary systems. This article reviews the clinical manifestations, diagnosis, and monitoring of patients with CF as well as guidelines for management and emerging pharmacologic treatments.